Industry Research Reports

Home > Reports > Service & Software > Global AI-based Clinical Trial Solution Market Research Report 2024

Global AI-based Clinical Trial Solution Market Research Report 2024

Industry: Service & Software

Published Date: 2024-02-07

Pages: 86 Pages

Report ld: 2196873

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Data integration, evolutionary modelling and pattern recognition using predictive AI models, can enable trial sponsors to aggregate, curate, and analyze large volumes of data, thereby, harnessing information captured during past trials to drive future therapy development initiatives,such as concerns related to clinical trial design, patient recruitment and retention, site selection, medical data interpretation and evaluation of treatment efficacy, which are encountered during trial conduct.

The global AI-based Clinical Trial Solution market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

AI is being used to enhance patient recruitment and retention in clinical trials. Predictive analytics and machine learning algorithms help identify eligible participants more efficiently, and personalized engagement strategies improve patient retention.

This report aims to provide a comprehensive presentation of the global market for AI-based Clinical Trial Solution, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI-based Clinical Trial Solution.

MARKET SEGMENTATION

By Company

AiCure
Antidote
Deep Lens
Saama Technologies
Trials.ai
Deep 6 AI
Innoplexus
Median Technologies
Mendel.ai
Phesi
Deloitte
Innoplexus
IBM

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Artificial Narrow Intelligence
Artificial General Intelligence
Artificial Super Intelligence

Segment by Application

Drug Discovery
Drug Manufacturing
Drug Marketing
Diagnosis and Treatment
Clinical Trials

biaoTi REPORT SCOPE

The AI-based Clinical Trial Solution market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global AI-based Clinical Trial Solution market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the AI-based Clinical Trial Solution companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of AI-based Clinical Trial Solution companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global AI-based Clinical Trial Solution Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Artificial Narrow Intelligence

1.2.3 Artificial General Intelligence

1.2.4 Artificial Super Intelligence

1.3 Market by Application

1.3.1 Global AI-based Clinical Trial Solution Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Drug Discovery

1.3.3 Drug Manufacturing

1.3.4 Drug Marketing

1.3.5 Diagnosis and Treatment

1.3.6 Clinical Trials

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global AI-based Clinical Trial Solution Market Perspective (2019-2030)

2.2 AI-based Clinical Trial Solution Growth Trends by Region

2.2.1 Global AI-based Clinical Trial Solution Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 AI-based Clinical Trial Solution Historic Market Size by Region (2019-2024)

2.2.3 AI-based Clinical Trial Solution Forecasted Market Size by Region (2025-2030)

2.3 AI-based Clinical Trial Solution Market Dynamics

2.3.1 AI-based Clinical Trial Solution Industry Trends

2.3.2 AI-based Clinical Trial Solution Market Drivers

2.3.3 AI-based Clinical Trial Solution Market Challenges

2.3.4 AI-based Clinical Trial Solution Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top AI-based Clinical Trial Solution Players by Revenue

3.1.1 Global Top AI-based Clinical Trial Solution Players by Revenue (2019-2024)

3.1.2 Global AI-based Clinical Trial Solution Revenue Market Share by Players (2019-2024)

3.2 Global AI-based Clinical Trial Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by AI-based Clinical Trial Solution Revenue

3.4 Global AI-based Clinical Trial Solution Market Concentration Ratio

3.4.1 Global AI-based Clinical Trial Solution Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by AI-based Clinical Trial Solution Revenue in 2023

3.5 AI-based Clinical Trial Solution Key Players Head office and Area Served

3.6 Key Players AI-based Clinical Trial Solution Product Solution and Service

3.7 Date of Enter into AI-based Clinical Trial Solution Market

3.8 Mergers & Acquisitions, Expansion Plans

4 AI-based Clinical Trial Solution Breakdown Data by Type

4.1 Global AI-based Clinical Trial Solution Historic Market Size by Type (2019-2024)

4.2 Global AI-based Clinical Trial Solution Forecasted Market Size by Type (2025-2030)

5 AI-based Clinical Trial Solution Breakdown Data by Application

5.1 Global AI-based Clinical Trial Solution Historic Market Size by Application (2019-2024)

5.2 Global AI-based Clinical Trial Solution Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America AI-based Clinical Trial Solution Market Size (2019-2030)

6.2 North America AI-based Clinical Trial Solution Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America AI-based Clinical Trial Solution Market Size by Country (2019-2024)

6.4 North America AI-based Clinical Trial Solution Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe AI-based Clinical Trial Solution Market Size (2019-2030)

7.2 Europe AI-based Clinical Trial Solution Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe AI-based Clinical Trial Solution Market Size by Country (2019-2024)

7.4 Europe AI-based Clinical Trial Solution Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific AI-based Clinical Trial Solution Market Size (2019-2030)

8.2 Asia-Pacific AI-based Clinical Trial Solution Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific AI-based Clinical Trial Solution Market Size by Region (2019-2024)

8.4 Asia-Pacific AI-based Clinical Trial Solution Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America AI-based Clinical Trial Solution Market Size (2019-2030)

9.2 Latin America AI-based Clinical Trial Solution Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America AI-based Clinical Trial Solution Market Size by Country (2019-2024)

9.4 Latin America AI-based Clinical Trial Solution Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa AI-based Clinical Trial Solution Market Size (2019-2030)

10.2 Middle East & Africa AI-based Clinical Trial Solution Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa AI-based Clinical Trial Solution Market Size by Country (2019-2024)

10.4 Middle East & Africa AI-based Clinical Trial Solution Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AiCure

11.1.1 AiCure Company Detail

11.1.2 AiCure Business Overview

11.1.3 AiCure AI-based Clinical Trial Solution Introduction

11.1.4 AiCure Revenue in AI-based Clinical Trial Solution Business (2019-2024)

11.1.5 AiCure Recent Development

11.2 Antidote

11.2.1 Antidote Company Detail

11.2.2 Antidote Business Overview

11.2.3 Antidote AI-based Clinical Trial Solution Introduction

11.2.4 Antidote Revenue in AI-based Clinical Trial Solution Business (2019-2024)

11.2.5 Antidote Recent Development

11.3 Deep Lens

11.3.1 Deep Lens Company Detail

11.3.2 Deep Lens Business Overview

11.3.3 Deep Lens AI-based Clinical Trial Solution Introduction

11.3.4 Deep Lens Revenue in AI-based Clinical Trial Solution Business (2019-2024)

11.3.5 Deep Lens Recent Development

11.4 Saama Technologies

11.4.1 Saama Technologies Company Detail

11.4.2 Saama Technologies Business Overview

11.4.3 Saama Technologies AI-based Clinical Trial Solution Introduction

11.4.4 Saama Technologies Revenue in AI-based Clinical Trial Solution Business (2019-2024)

11.4.5 Saama Technologies Recent Development

11.5 Trials.ai

11.5.1 Trials.ai Company Detail

11.5.2 Trials.ai Business Overview

11.5.3 Trials.ai AI-based Clinical Trial Solution Introduction

11.5.4 Trials.ai Revenue in AI-based Clinical Trial Solution Business (2019-2024)

11.5.5 Trials.ai Recent Development

11.6 Deep 6 AI

11.6.1 Deep 6 AI Company Detail

11.6.2 Deep 6 AI Business Overview

11.6.3 Deep 6 AI AI-based Clinical Trial Solution Introduction

11.6.4 Deep 6 AI Revenue in AI-based Clinical Trial Solution Business (2019-2024)

11.6.5 Deep 6 AI Recent Development

11.7 Innoplexus

11.7.1 Innoplexus Company Detail

11.7.2 Innoplexus Business Overview

11.7.3 Innoplexus AI-based Clinical Trial Solution Introduction

11.7.4 Innoplexus Revenue in AI-based Clinical Trial Solution Business (2019-2024)

11.7.5 Innoplexus Recent Development

11.8 Median Technologies

11.8.1 Median Technologies Company Detail

11.8.2 Median Technologies Business Overview

11.8.3 Median Technologies AI-based Clinical Trial Solution Introduction

11.8.4 Median Technologies Revenue in AI-based Clinical Trial Solution Business (2019-2024)

11.8.5 Median Technologies Recent Development

11.9 Mendel.ai

11.9.1 Mendel.ai Company Detail

11.9.2 Mendel.ai Business Overview

11.9.3 Mendel.ai AI-based Clinical Trial Solution Introduction

11.9.4 Mendel.ai Revenue in AI-based Clinical Trial Solution Business (2019-2024)

11.9.5 Mendel.ai Recent Development

11.10 Phesi

11.10.1 Phesi Company Detail

11.10.2 Phesi Business Overview

11.10.3 Phesi AI-based Clinical Trial Solution Introduction

11.10.4 Phesi Revenue in AI-based Clinical Trial Solution Business (2019-2024)

11.10.5 Phesi Recent Development

11.11 Deloitte

11.11.1 Deloitte Company Detail

11.11.2 Deloitte Business Overview

11.11.3 Deloitte AI-based Clinical Trial Solution Introduction

11.11.4 Deloitte Revenue in AI-based Clinical Trial Solution Business (2019-2024)

11.11.5 Deloitte Recent Development

11.12 Innoplexus

11.12.1 Innoplexus Company Detail

11.12.2 Innoplexus Business Overview

11.12.3 Innoplexus AI-based Clinical Trial Solution Introduction

11.12.4 Innoplexus Revenue in AI-based Clinical Trial Solution Business (2019-2024)

11.12.5 Innoplexus Recent Development

11.13 IBM

11.13.1 IBM Company Detail

11.13.2 IBM Business Overview

11.13.3 IBM AI-based Clinical Trial Solution Introduction

11.13.4 IBM Revenue in AI-based Clinical Trial Solution Business (2019-2024)

11.13.5 IBM Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

TABLE OF FIGURES

List of Tables

Table 1. Global AI-based Clinical Trial Solution Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Artificial Narrow Intelligence

Table 3. Key Players of Artificial General Intelligence

Table 4. Key Players of Artificial Super Intelligence

Table 5. Global AI-based Clinical Trial Solution Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global AI-based Clinical Trial Solution Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global AI-based Clinical Trial Solution Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global AI-based Clinical Trial Solution Market Share by Region (2019-2024)

Table 9. Global AI-based Clinical Trial Solution Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global AI-based Clinical Trial Solution Market Share by Region (2025-2030)

Table 11. AI-based Clinical Trial Solution Market Trends

Table 12. AI-based Clinical Trial Solution Market Drivers

Table 13. AI-based Clinical Trial Solution Market Challenges

Table 14. AI-based Clinical Trial Solution Market Restraints

Table 15. Global AI-based Clinical Trial Solution Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global AI-based Clinical Trial Solution Market Share by Players (2019-2024)

Table 17. Global Top AI-based Clinical Trial Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI-based Clinical Trial Solution as of 2023)

Table 18. Ranking of Global Top AI-based Clinical Trial Solution Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by AI-based Clinical Trial Solution Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players AI-based Clinical Trial Solution Product Solution and Service

Table 22. Date of Enter into AI-based Clinical Trial Solution Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global AI-based Clinical Trial Solution Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global AI-based Clinical Trial Solution Revenue Market Share by Type (2019-2024)

Table 26. Global AI-based Clinical Trial Solution Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global AI-based Clinical Trial Solution Revenue Market Share by Type (2025-2030)

Table 28. Global AI-based Clinical Trial Solution Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global AI-based Clinical Trial Solution Revenue Market Share by Application (2019-2024)

Table 30. Global AI-based Clinical Trial Solution Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global AI-based Clinical Trial Solution Revenue Market Share by Application (2025-2030)

Table 32. North America AI-based Clinical Trial Solution Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America AI-based Clinical Trial Solution Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America AI-based Clinical Trial Solution Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe AI-based Clinical Trial Solution Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe AI-based Clinical Trial Solution Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe AI-based Clinical Trial Solution Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific AI-based Clinical Trial Solution Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific AI-based Clinical Trial Solution Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific AI-based Clinical Trial Solution Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America AI-based Clinical Trial Solution Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America AI-based Clinical Trial Solution Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America AI-based Clinical Trial Solution Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa AI-based Clinical Trial Solution Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa AI-based Clinical Trial Solution Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa AI-based Clinical Trial Solution Market Size by Country (2025-2030) & (US$ Million)

Table 47. AiCure Company Detail

Table 48. AiCure Business Overview

Table 49. AiCure AI-based Clinical Trial Solution Product

Table 50. AiCure Revenue in AI-based Clinical Trial Solution Business (2019-2024) & (US$ Million)

Table 51. AiCure Recent Development

Table 52. Antidote Company Detail

Table 53. Antidote Business Overview

Table 54. Antidote AI-based Clinical Trial Solution Product

Table 55. Antidote Revenue in AI-based Clinical Trial Solution Business (2019-2024) & (US$ Million)

Table 56. Antidote Recent Development

Table 57. Deep Lens Company Detail

Table 58. Deep Lens Business Overview

Table 59. Deep Lens AI-based Clinical Trial Solution Product

Table 60. Deep Lens Revenue in AI-based Clinical Trial Solution Business (2019-2024) & (US$ Million)

Table 61. Deep Lens Recent Development

Table 62. Saama Technologies Company Detail

Table 63. Saama Technologies Business Overview

Table 64. Saama Technologies AI-based Clinical Trial Solution Product

Table 65. Saama Technologies Revenue in AI-based Clinical Trial Solution Business (2019-2024) & (US$ Million)

Table 66. Saama Technologies Recent Development

Table 67. Trials.ai Company Detail

Table 68. Trials.ai Business Overview

Table 69. Trials.ai AI-based Clinical Trial Solution Product

Table 70. Trials.ai Revenue in AI-based Clinical Trial Solution Business (2019-2024) & (US$ Million)

Table 71. Trials.ai Recent Development

Table 72. Deep 6 AI Company Detail

Table 73. Deep 6 AI Business Overview

Table 74. Deep 6 AI AI-based Clinical Trial Solution Product

Table 75. Deep 6 AI Revenue in AI-based Clinical Trial Solution Business (2019-2024) & (US$ Million)

Table 76. Deep 6 AI Recent Development

Table 77. Innoplexus Company Detail

Table 78. Innoplexus Business Overview

Table 79. Innoplexus AI-based Clinical Trial Solution Product

Table 80. Innoplexus Revenue in AI-based Clinical Trial Solution Business (2019-2024) & (US$ Million)

Table 81. Innoplexus Recent Development

Table 82. Median Technologies Company Detail

Table 83. Median Technologies Business Overview

Table 84. Median Technologies AI-based Clinical Trial Solution Product

Table 85. Median Technologies Revenue in AI-based Clinical Trial Solution Business (2019-2024) & (US$ Million)

Table 86. Median Technologies Recent Development

Table 87. Mendel.ai Company Detail

Table 88. Mendel.ai Business Overview

Table 89. Mendel.ai AI-based Clinical Trial Solution Product

Table 90. Mendel.ai Revenue in AI-based Clinical Trial Solution Business (2019-2024) & (US$ Million)

Table 91. Mendel.ai Recent Development

Table 92. Phesi Company Detail

Table 93. Phesi Business Overview

Table 94. Phesi AI-based Clinical Trial Solution Product

Table 95. Phesi Revenue in AI-based Clinical Trial Solution Business (2019-2024) & (US$ Million)

Table 96. Phesi Recent Development

Table 97. Deloitte Company Detail

Table 98. Deloitte Business Overview

Table 99. Deloitte AI-based Clinical Trial Solution Product

Table 100. Deloitte Revenue in AI-based Clinical Trial Solution Business (2019-2024) & (US$ Million)

Table 101. Deloitte Recent Development

Table 102. Innoplexus Company Detail

Table 103. Innoplexus Business Overview

Table 104. Innoplexus AI-based Clinical Trial Solution Product

Table 105. Innoplexus Revenue in AI-based Clinical Trial Solution Business (2019-2024) & (US$ Million)

Table 106. Innoplexus Recent Development

Table 107. IBM Company Detail

Table 108. IBM Business Overview

Table 109. IBM AI-based Clinical Trial Solution Product

Table 110. IBM Revenue in AI-based Clinical Trial Solution Business (2019-2024) & (US$ Million)

Table 111. IBM Recent Development

Table 112. Research Programs/Design for This Report

Table 113. Key Data Information from Secondary Sources

Table 114. Key Data Information from Primary Sources

List of Figures

Figure 1. Global AI-based Clinical Trial Solution Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global AI-based Clinical Trial Solution Market Share by Type: 2023 VS 2030

Figure 3. Artificial Narrow Intelligence Features

Figure 4. Artificial General Intelligence Features

Figure 5. Artificial Super Intelligence Features

Figure 6. Global AI-based Clinical Trial Solution Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global AI-based Clinical Trial Solution Market Share by Application: 2023 VS 2030

Figure 8. Drug Discovery Case Studies

Figure 9. Drug Manufacturing Case Studies

Figure 10. Drug Marketing Case Studies

Figure 11. Diagnosis and Treatment Case Studies

Figure 12. Clinical Trials Case Studies

Figure 13. AI-based Clinical Trial Solution Report Years Considered

Figure 14. Global AI-based Clinical Trial Solution Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global AI-based Clinical Trial Solution Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global AI-based Clinical Trial Solution Market Share by Region: 2023 VS 2030

Figure 17. Global AI-based Clinical Trial Solution Market Share by Players in 2023

Figure 18. Global Top AI-based Clinical Trial Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI-based Clinical Trial Solution as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by AI-based Clinical Trial Solution Revenue in 2023

Figure 20. North America AI-based Clinical Trial Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America AI-based Clinical Trial Solution Market Share by Country (2019-2030)

Figure 22. United States AI-based Clinical Trial Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada AI-based Clinical Trial Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe AI-based Clinical Trial Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe AI-based Clinical Trial Solution Market Share by Country (2019-2030)

Figure 26. Germany AI-based Clinical Trial Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France AI-based Clinical Trial Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. AI-based Clinical Trial Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy AI-based Clinical Trial Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia AI-based Clinical Trial Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries AI-based Clinical Trial Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific AI-based Clinical Trial Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific AI-based Clinical Trial Solution Market Share by Region (2019-2030)

Figure 34. China AI-based Clinical Trial Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan AI-based Clinical Trial Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea AI-based Clinical Trial Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia AI-based Clinical Trial Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India AI-based Clinical Trial Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia AI-based Clinical Trial Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America AI-based Clinical Trial Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America AI-based Clinical Trial Solution Market Share by Country (2019-2030)

Figure 42. Mexico AI-based Clinical Trial Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil AI-based Clinical Trial Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa AI-based Clinical Trial Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa AI-based Clinical Trial Solution Market Share by Country (2019-2030)

Figure 46. Turkey AI-based Clinical Trial Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia AI-based Clinical Trial Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. AiCure Revenue Growth Rate in AI-based Clinical Trial Solution Business (2019-2024)

Figure 49. Antidote Revenue Growth Rate in AI-based Clinical Trial Solution Business (2019-2024)

Figure 50. Deep Lens Revenue Growth Rate in AI-based Clinical Trial Solution Business (2019-2024)

Figure 51. Saama Technologies Revenue Growth Rate in AI-based Clinical Trial Solution Business (2019-2024)

Figure 52. Trials.ai Revenue Growth Rate in AI-based Clinical Trial Solution Business (2019-2024)

Figure 53. Deep 6 AI Revenue Growth Rate in AI-based Clinical Trial Solution Business (2019-2024)

Figure 54. Innoplexus Revenue Growth Rate in AI-based Clinical Trial Solution Business (2019-2024)

Figure 55. Median Technologies Revenue Growth Rate in AI-based Clinical Trial Solution Business (2019-2024)

Figure 56. Mendel.ai Revenue Growth Rate in AI-based Clinical Trial Solution Business (2019-2024)

Figure 57. Phesi Revenue Growth Rate in AI-based Clinical Trial Solution Business (2019-2024)

Figure 58. Deloitte Revenue Growth Rate in AI-based Clinical Trial Solution Business (2019-2024)

Figure 59. Innoplexus Revenue Growth Rate in AI-based Clinical Trial Solution Business (2019-2024)

Figure 60. IBM Revenue Growth Rate in AI-based Clinical Trial Solution Business (2019-2024)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global AI-based Clinical Trial Solution market? zhanKai

The top companies in the global AI-based Clinical Trial Solution market are AiCure、Antidote、Deep Lens.

Related Reports

Global AI-based Clinical Trial Solution Market Outlook, In‑Depth Analysis & Forecast to 2032
The global AI-based Clinical Trial Solution market is projected to grow from US$ 2715 million in 2025 to US$ 13122 million by 2032, at a CAGR of 25.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-09
Pages: 153
USD 4900.00
(Single User License)
Global AI-based Clinical Trial Solution Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global AI-based Clinical Trial Solution market size was US$ 2715 million in 2025 and is forecast to reach a readjusted size of US$ 13122 million by 2032 with a CAGR of 25.2% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 101
USD 4250.00
(Single User License)
AI-based Clinical Trial Solution - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for AI-based Clinical Trial Solution was estimated to be worth US$ 2715 million in 2025 and is projected to reach US$ 13122 million, growing at a CAGR of 25.2% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 135
USD 3950.00
(Single User License)
Global AI-based Clinical Trial Solution Market Research Report 2026
The global AI-based Clinical Trial Solution market was valued at US$ 2715 million in 2025 and is anticipated to reach US$ 13122 million by 2032, at a CAGR of 25.2% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 137
USD 2900.00
(Single User License)
Global AI-based Clinical Trial Solution Market Outlook, In‑Depth Analysis & Forecast to 2031
The global AI-based Clinical Trial Solution market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-23
Pages: 142
USD 4900.00
(Single User License)
Global AI-based Clinical Trial Solution Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global AI-based Clinical Trial Solution market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 95
USD 4250.00
(Single User License)
AI-based Clinical Trial Solution- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for AI-based Clinical Trial Solution was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 117
USD 3950.00
(Single User License)
Global AI-based Clinical Trial Solution Market Research Report 2025
The global market for AI-based Clinical Trial Solution was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-20
Pages: 88
USD 2900.00
(Single User License)
Global AI-based Clinical Trial Solution Market Insights, Forecast to 2030
Data integration, evolutionary modelling and pattern recognition using predictive AI models, can enable trial sponsors to aggregate, curate, and analyze large volumes of data, thereby, harnessing information captured during past trials to drive future therapy development initiatives,such as concerns related to clinical trial design, patient recruitment and retention, site selection, medical data interpretation and evaluation of treatment efficacy, which are encountered during trial conduct.
Published Date: 2024-04-07
Pages: 106
USD 4900.00
(Single User License)
AI-based Clinical Trial Solution - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Data integration, evolutionary modelling and pattern recognition using predictive AI models, can enable trial sponsors to aggregate, curate, and analyze large volumes of data, thereby, harnessing information captured during past trials to drive future therapy development initiatives,such as concerns related to clinical trial design, patient recruitment and retention, site selection, medical data interpretation and evaluation of treatment efficacy, which are encountered during trial conduct.
Published Date: 2024-02-19
Pages: 102
USD 3950.00
(Single User License)

Global AI-based Clinical Trial Solution Market Outlook, In‑Depth Analysis & Forecast to 2032
The global AI-based Clinical Trial Solution market is projected to grow from US$ 2715 million in 2025 to US$ 13122 million by 2032, at a CAGR of 25.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-09
Pages: 153
USD 4900.00 (Single User License)
Global AI-based Clinical Trial Solution Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global AI-based Clinical Trial Solution market size was US$ 2715 million in 2025 and is forecast to reach a readjusted size of US$ 13122 million by 2032 with a CAGR of 25.2% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 101
USD 4250.00 (Single User License)
AI-based Clinical Trial Solution - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for AI-based Clinical Trial Solution was estimated to be worth US$ 2715 million in 2025 and is projected to reach US$ 13122 million, growing at a CAGR of 25.2% from 2026 to 2032.
Published: 2026-03-05
Pages: 135
USD 3950.00 (Single User License)
Global AI-based Clinical Trial Solution Market Research Report 2026
The global AI-based Clinical Trial Solution market was valued at US$ 2715 million in 2025 and is anticipated to reach US$ 13122 million by 2032, at a CAGR of 25.2% from 2026 to 2032.
Published: 2026-03-05
Pages: 137
USD 2900.00 (Single User License)
Global AI-based Clinical Trial Solution Market Outlook, In‑Depth Analysis & Forecast to 2031
The global AI-based Clinical Trial Solution market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-23
Pages: 142
USD 4900.00 (Single User License)
Global AI-based Clinical Trial Solution Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global AI-based Clinical Trial Solution market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 95
USD 4250.00 (Single User License)
AI-based Clinical Trial Solution- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for AI-based Clinical Trial Solution was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 117
USD 3950.00 (Single User License)
Global AI-based Clinical Trial Solution Market Research Report 2025
The global market for AI-based Clinical Trial Solution was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-20
Pages: 88
USD 2900.00 (Single User License)
Global AI-based Clinical Trial Solution Market Insights, Forecast to 2030
Data integration, evolutionary modelling and pattern recognition using predictive AI models, can enable trial sponsors to aggregate, curate, and analyze large volumes of data, thereby, harnessing information captured during past trials to drive future therapy development initiatives,such as concerns related to clinical trial design, patient recruitment and retention, site selection, medical data interpretation and evaluation of treatment efficacy, which are encountered during trial conduct.
Published: 2024-04-07
Pages: 106
USD 4900.00 (Single User License)
AI-based Clinical Trial Solution - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Data integration, evolutionary modelling and pattern recognition using predictive AI models, can enable trial sponsors to aggregate, curate, and analyze large volumes of data, thereby, harnessing information captured during past trials to drive future therapy development initiatives,such as concerns related to clinical trial design, patient recruitment and retention, site selection, medical data interpretation and evaluation of treatment efficacy, which are encountered during trial conduct.
Published: 2024-02-19
Pages: 102
USD 3950.00 (Single User License)